Developed skills and lines of research

Federico Alghisi graduated in Medicine and Surgery from Sapienza University of Rome in 2000. He completed his specialization in Gastroenterology at the same university in 2006. Since 2007, he has been working at the Cystic Fibrosis Center of Bambino Gesù Children’s Hospital in Rome, where he currently serves as a first level medical director and as a principal investigator in selected clinical trials within the European Clinical Trial Network.

Projects financed by FFC Ricerca as a partner

FFC#14/2024
Long-term clinical outcomes of insulin secretory defects and effects of CFTR modulators

Publications from FFC Ricerca projects

• Angyal D, Kleinfelder K, Ciciriello F, Groeneweg TA, De Marchi G, de Pretis N, Bernardoni L, Rodella L, Tomba F, De Angelis P, Surace C, Pintani E, Alghisi F, de Jonge HR, Melotti P, Sorio C, Lucidi V, Bijvelds MJC, Frulloni L. CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants. Pancreatology. 2024 May;24(3):394-403. doi: 10.1016/j.pan.2024.03.005. Epub 2024 Mar 10. PMID: 38493004.
• Ciciriello F, Foppiani A, Sileo F, Alghisi F, Russo MC, Claut LE, Bisogno A, Costa S, Lucanto MC, Lucidi V, Colombo C, Battezzati A. Mutations with residual CFTR function are associated with better glucose tolerance and insulin secretion in people with Cystic fibrosis. J Cyst Fibros. 2026 Mar;25(2):319-327. doi: 10.1016/j.jcf.2025.11.001. Epub 2025 Nov 14. PMID: 41241605.